✦ LIBER ✦

EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients: how do we interpret the clinical and biomarker data?

✍ Scribed by Raffaele Califano; Fiona H. Blackhall; Giovanna Finocchiaro; Luca Toschi; Nicholas Thatcher; Federico Cappuzzo; Lucio Crinò

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activating and resistance mutations of E

✍ Gazdar, A F 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 213 KB

The Potential Clinical and Economic Outc

✍ Josh J. Carlson; Louis P. Garrison; Scott D. Ramsey; David L. Veenstra 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

Epidermal growth factor receptor (EGFR)

✍ Elena María Martínez-Navarro; Joseba Rebollo; Ramón González-Manzano; Manuel Sur 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 230 KB

Overview of molecular testing in non-sma

✍ John, T; Liu, G; Tsao, M-S 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 293 KB